Kura Oncology, Inc. (KURA)

Kura Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	875	677	1,068	847	932	2,157
Market Cap Growth	-43.51%	-36.58%	26.07%	-9.08%	-56.80%	246.13%
Enterprise Value	264	239	633	425	396	1,847
Last Close Price	10.08	8.71	14.38	12.41	14.00	32.66
PS Ratio	10.56	12.57	-	-	-	-
PB Ratio	2.86	1.64	2.69	2.02	1.84	3.53
P/TBV Ratio	2.86	1.64	2.69	2.02	1.84	3.53
P/FCF Ratio	7.12	5.06	-	-	-	-
P/OCF Ratio	7.00	5.04	-	-	-	-
EV/Sales Ratio	3.17	4.43	-	-	-	-
EV/FCF Ratio	2.15	1.78	-	-	-	-
Debt / Equity Ratio	0.06	0.04	0.04	0.03	0.01	0.03
Debt / FCF Ratio	0.16	0.12	-	-	-	-
Asset Turnover	0.14	0.09	-	-	-	-
Quick Ratio	5.93	9.32	12.05	18.24	23.13	24.34
Current Ratio	6.16	9.46	12.26	18.56	23.26	24.49
Return on Equity (ROE)	-51.11%	-42.91%	-37.34%	-29.31%	-23.35%	-21.60%
Return on Assets (ROA)	-22.93%	-19.97%	-22.89%	-17.65%	-13.89%	-12.92%
Return on Capital (ROIC)	-34.00%	-28.59%	-24.42%	-18.45%	-14.40%	-13.48%
Earnings Yield	-22.54%	-25.69%	-14.29%	-16.04%	-14.00%	-4.16%
FCF Yield	14.04%	19.76%	-11.70%	-13.07%	-11.34%	-3.34%
Buyback Yield / Dilution	-7.33%	-17.66%	-9.31%	-0.96%	-25.01%	-26.54%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q